Natural Capsules Approves Preferential Issue of Shares and Warrants, Boosts Promoter Holding
Natural Capsules approved a preferential issue of 1,12,500 equity shares and 4,50,000 warrants at ₹178 each. The issue aims to increase promoter holding to 10.61%. An EGM is scheduled for September 9, 2026. The preferential issue aggregates ₹2,00,25,000 for shares and ₹8,01,00,000 for warrants.
The preferential issue involves a significant amount of capital and will increase promoter stake, potentially impacting corporate governance and future strategic decisions. The increase in share capital could also affect existing shareholders' dilution.
The company is undertaking a preferential issue to strengthen its capital structure and increase promoter holding, which is generally viewed positively. The approval of the EGM notice also indicates progress on corporate actions.
Natural Capsules Limited announced the outcome of its Board Meeting held on September 02, 2026, where several key decisions were made regarding a preferential issue.
The Board approved the revised price and quantity for a preferential issue of up to 1,12,500 equity shares of face value ₹10 each, at an issue price of ₹178 per share. This issue is intended for persons belonging to the promoter/promoter group and is subject to shareholder and regulatory approvals.
Additionally, the company approved the issuance of 4,50,000 convertible warrants, each convertible into one equity share of face value ₹10, also at an issue price of ₹178 per warrant. A minimum of 25% of the warrant issue price is payable at the time of subscription, with the balance due upon exercise. These warrants are also for the promoter/promoter group and require member and regulatory approvals.
The pricing and quantity adjustments were based on a Valuation Report dated August 31, 2026, issued by a registered valuer, in response to queries from BSE and NSE, and in compliance with SEBI regulations.
Furthermore, the Board approved a Corrigendum Notice for the Extra Ordinary General Meeting (EGM) scheduled for September 09, 2026. The meeting was convened at shorter notice due to the late receipt of the Valuation Report on August 31, 2026, and the urgent need to dispatch the Corrigendum Notice by September 02, 2026, to meet statutory timelines.
The preferential issue of equity shares aggregates to ₹2,00,25,000, and the issuance of warrants aggregates to ₹8,01,00,000. Post the full conversion of warrants, the promoter shareholding is expected to increase from 5.79% to 10.61%. Warrants are convertible within 18 months from the allotment date, with a forfeiture clause for failure to exercise within the stipulated period.
A plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.